Australian Story - Gunnings & Stehn, page-54

The work Novogen took control over in late 2013 that was the ATM program and the fore runner to Anisina - began all the way back in 1980 - 14 years before the original Novogen was floated creating treatments for menopause with Red Clover...

35 years of persistence by Professor Gunning to develop a better treatment for children's cancers is a very worthy pursuit...

Just imagine if team Novogen can get Anisina through the clinic - Professor Gunning would be up for National if not International recognition and since 2003 has been funded by charities especially the Kids Cancer Project to the tune of around 1 million dollars a year...
Novogen would also be recognised as being pivotal to the development as well as Genscreen & UNSW & The Kids Cancer Project..but Professor Gunning stayed with it for all those years - possibly foregoing other lucrative ventures and remaining focused...

He now sits on the Novogen board and is privy to not only the research being done on the ATM program but also the SBP program as well as both are designed to be complimentary and he carefully vetts the results...... governance in companies is all to important for shareholder TRUST and a man who pursues a line of research for 35 years on childhood cancer sounds pretty good to me to be scrutinising results...